Takeda: all 1,753 studies

Page 13 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in BrazilCompletedNCT05626088
• A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)CompletedNCT05596422
• A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in CanadaCompletedNCT05578417
• A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and CanadaCompletedNCT05576805
• A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and CanadaCompletedNCT05571137
• A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)CompletedNCT05561647
• A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARACompletedNCT05556629
• A Survey of Icatibant in Pediatric Participants With Hereditary AngioedemaCompletedNCT05509569
• A Study of People With CD30 Positive Lymphoma in ChinaCompletedNCT05506774
• A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)WithdrawnNCT05494593Phase 4
• A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at HomeCompletedNCT05489640
• A Study of Purified Inactivated Zika Virus Vaccine (PIZV) in Healthy AdultsWithdrawnNCT05469802Phase 2
• A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)Active, not recruitingNCT05469789
• A Study of RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-EmphysemaWithdrawnNCT05466747Phase 4
• A Spanish Medical Record Review of Clinical Characteristics and Outcomes in Non-small Cell Lung Cancer Participants With EGFR Exon 20 InsertionCompletedNCT05419700
• A Survey of Lanadelumab in Participants With Hereditary AngioedemaActive, not recruitingNCT05397431
• A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in PolandCompletedNCT05384080
• A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in CanadaCompletedNCT05371028
• A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT05363358
• A Study of Medical Records From Children With Central Precocious Puberty (CPP) in ChinaCompletedNCT05341128
• A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc IntervalWithdrawnNCT05309902Phase 1
• Virtual Celiac Symptoms Study in Adults and TeenagersCompletedNCT05309330
• A Study of Chinese Adults With LymphomaCompletedNCT05288491
• A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and AdultsCompletedNCT05269082
• A Study on Estimated Risks of Certain Adverse Events in Adults With Von Willebrand Disease (VWD) Treated With VeyvondiCompletedNCT05265078
• A Chart Review Study of Adults With Advanced NSCLCCompletedNCT05207423
• A Study of Vedolizumab in Adults With Crohn's Disease (CD)CompletedNCT05192863
• A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple MyelomaWithdrawnNCT05183139Phase 4
• A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep ApneaCompletedNCT05180890Phase 1
• A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background TherapyCompletedNCT05174221Phase 1
• A Study to Improve the Awareness of Mucopolysaccharidosis Type II in BrazilCompletedNCT05155488
• A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in PolandCompletedNCT05147181
• A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in EnglandCompletedNCT05137704
• Retrospective Study on Participants With Short Bowel Syndrome and Chronic Intestinal Failure That Underwent Transplantation in BrazilCompletedNCT05113082
• Early Detection of Fabry DiseaseCompletedNCT05106764
• Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular CarcinomaCompletedNCT05100082
• A Study Reviewing Medical Records of Adults With Helicobacter Pylori Infections in ChinaCompletedNCT05073367
• A Study of Real-World Outcomes of People With Crohn's Disease (CD)CompletedNCT05056441
• An Additional Analysis of Data From the PARADIGM Exploratory Study (NCT02394834) in Patients With Advanced/Recurrent Colorectal CancerActive, not recruitingNCT05030493
• A Study of Danavorexton in Anesthetized AdultsCompletedNCT05025397Phase 1
• A Study of Teduglutide in Japanese People With Short Bowel SyndromeCompletedNCT05023382
• A Study of Niraparib in Patients With Ovarian Cancer in Clinical PracticeCompletedNCT05021562
• A Study of NINLARO® in Chinese Adults With Multiple MyelomaActive, not recruitingNCT05013190
• A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotinCompletedNCT04998331
• A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in SwitzerlandCompletedNCT04989907
• A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic SyndromesWithdrawnNCT04985656Phase 2
• A Study of Real Life Treatment for Multiple Myeloma (MM)Active, not recruitingNCT04985643
• A Study to Check How Often People Treated With Darvadstrocel for Crohn's Disease Are Diagnosed With CancerWithdrawnNCT04971525
• A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During PregnancyActive, not recruitingNCT04961840
• A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)CompletedNCT04959851
• A Study of the Burden of Illness and Treatment Patterns in Teenagers and Adults With Hereditary AngioedemaCompletedNCT04957641
• A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in ArgentinaCompletedNCT04955964
• A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia ACompletedNCT04953000
• A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of LifeCompletedNCT04943796
• A Study of Surgical Interventions in Fistulizing ConditionsCompletedNCT04940611
• Assessment of Updated Educational Materials for Instanyl®CompletedNCT04938440
• Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 SymptomsWithdrawnNCT04892888
• A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World PracticeCompletedNCT04890262
• A Study of Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC)CompletedNCT04887519
• A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA)CompletedNCT04885920
• A Study With Teduglutide (Revestive®) in Adults With Short Bowl SyndromeCompletedNCT04883606
• A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel DiseaseCompletedNCT04877431
• A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to AdynovateCompletedNCT04876365
• A Study of Vedolizumab in Adults in Real-World PracticeCompletedNCT04872491
• Post-Marketing Study of Prucalopride Safety In PregnancyActive, not recruitingNCT04869280
• Drug Use Study With VYVANSE® in Australia for Binge Eating DisorderCompletedNCT04866043
• Drug Use Study With Intuniv® in AustraliaCompletedNCT04866030
• A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term ProphylaxisCompletedNCT04861090
• Drug Use Study of Febuxostat After Recent Changes in the Prescribing InformationCompletedNCT04853160
• A Study Using Artificial Intelligence to Identify Adults With Complex Perianal Fistulas Associated With Crohn's DiseaseCompletedNCT04844593
• A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)CompletedNCT04840680
• A Study of Brentuximab Vedotin in Adults With CD30-positive LymphomaCompletedNCT04837222
• Study to Evaluate Absorption, Metabolism, and Excretion, of TAK-994 in 6 Healthy Male AdultsCompletedNCT04833049Phase 1
• Bioavailability and Food Effect Study of Two Formulations of TAK-906WithdrawnNCT04831502Phase 1
• A Study of CDPATH™ to Help Manage and Treat Crohn's DiseaseCompletedNCT04809363Phase 4
• A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic PouchitisCompletedNCT04799496
• A Study of Different Forms of TAK-994 in Healthy AdultsCompletedNCT04745767Phase 1
• A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Young Children With Gaucher DiseaseCompletedNCT04721366
• A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic PurpuraActive, not recruitingNCT04683003Phase 3
• A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life PracticeCompletedNCT04659798
• Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID)CompletedNCT04636502
• Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in EuropeCompletedNCT04597905
• A Study of Usage of Brigatinib in the Treatment of Adult Participants for Approved Indications In South KoreaCompletedNCT04592523
• A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South KoreaCompletedNCT04589039
• Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and AdultsNo longer availableNCT04583007
• A Study to Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788WithdrawnNCT04576208Phase 2
• A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male ParticipantsCompletedNCT04551079Phase 1
• An Expanded Access Protocol for Mobocertinib in Refractory Non-small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Exon20 Insertion MutationsApproved for marketingNCT04535557
• A Study on Vonoprazan in the Real-world Clinical Practice in ChinaCompletedNCT04501627
• Expanded Access Program With Pevonedistat (Given With Azacitidine) for Adults With Higher-risk Myelodysplastic SyndromesNo longer availableNCT04484363
• A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in AdultsWithdrawnNCT04464460Phase 1
• Lanadelumab in Participants Hospitalized With COVID-19 PneumoniaWithdrawnNCT04460105Phase 1
• Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy ParticipantsCompletedNCT04445129
• ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) StudyWithdrawnNCT04440488Phase 4
• Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in IndiaCompletedNCT04429984
• A Study of TAK-102 in Adult With Previously-Treated Solid TumorsTerminatedNCT04405778Phase 1
• ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily PracticeWithdrawnNCT04349449
• A Study of Ninlaro in Real World Clinical Practice in ChinaCompletedNCT04328662
• A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian FederationWithdrawnNCT04311541
• Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid TumorsWithdrawnNCT04260009Phase 1/2

← Takeda overview and focus areas